Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Therapeutic Drug Monitoring|February 25, 2025
Olanzapine; Postinjection Syndrome; Pharmacokinetics in View: Grand Round/A Case StudyJohanne Rozema, Cornelis Paul van Stee, Daniel J Touw, et al.Journal of Geriatric Oncology|January 19, 2023
Treatment patterns in older patients with myelodysplastic syndromes: A population-based analysis reflecting the real worldJohanne Rozema, Jetske Graafsma, Mels Hoogendoorn, et al.Blood Advances|March 3, 2021
Comorbidities and malignancies negatively affect survival in myelodysplastic syndromes: a population-based studyJohanne Rozema, Mels Hoogendoorn, Robby Kibbelaar, et al.European Journal of Haematology|June 26, 2022
Management of infection prophylaxis in Dutch patients with myelodysplastic syndromes, a web-based case vignette questionnaire: The MINDSET studyJohanne Rozema, Eric van Roon, Lars Vogelzang, et al.Cancers|December 17, 2024
The Evolution of Treatment Policies and Outcomes for Patients Aged 60 and Older with Acute Myeloid Leukemia: A Population-Based Analysis over Two DecadesBenno Diekmann, Nic Veeger, Johanne Rozema, et al.Transfusion|September 4, 2021
Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population-based studyJohanne Rozema, Eric N van Roon, Robby E Kibbelaar, et al.Blood Transfusion = Trasfusione Del Sangue|December 28, 2020
A clinical effect of disease-modifying treatment on alloimmunisation in transfused patients with myelodysplastic syndromes: data from a population-based studyJohanne Rozema, Christiaan L Slim, Nic J G M Veeger, et al.European Journal of Haematology|September 21, 2022
Clinical view versus guideline adherence in ferritin monitoring and initiating iron chelation therapy in patients with myelodysplastic syndromesJohanne Rozema, Ivar van Asten, Beau Kwant, et al.Ejhaem|September 2, 2022
Increased prescription rate of anti-infective agents after diagnosis of myelodysplastic syndromesJohanne Rozema, Mels Hoogendoorn, Iris Potma, et al.Pageof 1